The global antisense and RNAi therapeutics market was estimated at USD 4.38 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 18.72% from 2024 to 2030. Antisense technology is useful for gene expression manipulation, which has been recognized as a success... Read More »
February 2024The global morphine drugs market size was valued at USD 23.86 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.69% from 2024 to 2030. The wide use of morphine in pain management is anticipated to drive the market growth. Furthermore, the prevalence of ... Read More »
February 2024The global vitamin D therapy market size was valued at USD 2.04 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.06% from 2024 to 2030. The vitamin D therapy market is being driven by the growing awareness of the health benefits associated with vitamin... Read More »
February 2024The global loratadine market size was valued at USD 153.4 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2030. The high prevalence rate of allergies worldwide, changing lifestyles, and favorable regulatory landscape are significant as... Read More »
February 2024The global tinea pedis treatment market was valued at USD 1.3 billion in 2023 and is expected to grow at a CAGR of 7.09 % from 2024-2030. The market is experiencing growth due to the increasing prevalence of fungal foot infections globally, changing lifestyles, rising awareness about the... Read More »
February 2024The global cough remedies market size was valued at USD 9.90 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.51% from 2024 to 2030. Asthma, chronic pulmonary obstructive disease (COPD), cold, flu, bronchitis, pertussis, and allergies are some of the m... Read More »
February 2024The global hydroxyzine market size is expected to grow at a compound annual growth rate (CAGR) of over 6.0% from 2024 to 2030. The growing prevalence of anxiety disorders and atopic contact dermatitis has created immense opportunities for key market players. In addition, some of the othe... Read More »
February 2024The global fungal keratitis treatment market size was valued at USD 928.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024 to 2030. Fungal keratitis, an infection affecting the cornea, the transparent covering over the eye’s-colored... Read More »
February 2024The global graft versus host disease (GvHD) treatment market size was valued at USD 2.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2030. The rise in the elderly population and an increase in the occurrence of nephrological, leukem... Read More »
February 2024The global over the counter (OTC) drugs market size was estimated at USD 189.3 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.92 from 2024- 2030. The growth can be attributed to factors such as increasing consumer willingness to spend on OTC medication, growing consumer awarene... Read More »
February 2024The global ibuprofen API market size was valued at USD 700.8 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 1.17% from 2024 to 2030. The evolving API scenario in emerging economies, the increase in pharmaceutical and biopharmaceutical production, and t... Read More »
February 2024The global methicillin-resistant staphylococcus aureus drugs market was valued at USD 2.15 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.51% from 2024 to 2030. This can be attributed to the pipeline space, and major pharmaceutical firms are advancin... Read More »
February 2024The global triamcinolone ointment chlorofluorocarbons market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 1.6% from 2024 to 2030. Triamcinolone ointment, a topical corticosteroid, plays a vital role in treating various skin conditions like eczema, psoriasis, and de... Read More »
February 2024The global ulcerative colitis market size was valued at USD 636.98 million in 2023 and is expected to grow at a CAGR of 6.43% during the forecast period 2024-2030. One of the key driving factors attributed to the growth of the ulcerative colitis market is the increasing prevalence of the... Read More »
February 2024The global infectious enteritis treatment market size was valued at USD 453.46 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024 to 2030. The enduringly high prevalence of infectious enteritis, including conditions such as gastroenteritis ... Read More »
February 2024The global influenza medications market size was valued at USD 928.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024-2030. The increasing incidence of influenza is set to drive the global demand for influenza medications. The growing ger... Read More »
February 2024The global dacryocystitis market size expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2030. The increasing prevalence of eye infections and technological advancements, growing clinical research, and subsequent new product launches boost the market growth. Fu... Read More »
February 2024The global compound camphor ointment market size was valued at USD 2.55 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.15% from 2024 to 2030. Compound camphor ointment acts as an analgesic and is used for chest congestion caused by cold & itching... Read More »
February 2024The global trachoma treatment market size was valued at USD 514.6 million in 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.09% from 2024 to 2030. The market is experiencing growth due to the increasing incidence and prevalence of trachoma infectious disease. F... Read More »
February 2024The global anorexiants market size was valued around USD 900 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.77% from 2024 to 2030. Anorexiants, also known as appetite suppressants or weight loss medications, are drugs or pharmaceutical compounds spec... Read More »
February 2024